Janssen Needn't Show Earnings In Off-Label Use Suit

By Ryan Boysen · April 8, 2019, 9:26 PM EDT

Drugmaker Janssen Products LP doesn't have to turn over documents that show the profits it made by allegedly selling HIV/AIDS medication for off-label uses in violation of federal law, a New...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

UNITED STATES OF AMERICA et al v. JOHNSON & JOHNSON et al

Case Number

3:12-cv-07758

Court

New Jersey

Nature of Suit

Other Statutes: False Claims Act

Date Filed

December 18, 2012